Pharma Journalist -

BioFIT 2019: A great first edition in Marseille For its first phocean edition, BioFIT confirms its status as the leading European partnering event for early-stage deals and…
Read More...

Pharmaceutics International, Inc. (Pii), a pharmaceutical contract development and manufacturing organization (CDMO), announces the expansion of its aseptic filling capacity and…
Read More...

Lysogene, a pioneering Phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast…
Read More...

TwinStrand Biosciences announced the launch of TwinStrand Duplex Sequencing Technology kits at the annual Advances in Genome Biology and Technology (AGBT) General Meeting in Marco…
Read More...

EmCyte announces its FDA 510(k) clearance for its PurePRP Supraphysiologic Concentrating System for platelet rich plasma. The system's 510(k) number is BK190317 and is cleared to be…
Read More...

AstraZeneca has agreed to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada and Israel, to RedHill Biopharma (RedHill). Movantik is a peripherally acting…
Read More...

Novartis and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, have signed a collaboration and licence agreement to…
Read More...

Vir Biotechnology, Inc. and WuXi Biologics announced a development and manufacturing collaboration to advance and produce human monoclonal antibodies for the potential treatment of…
Read More...

Bicycle Therapeutics plc announced that it has entered into a strategic collaboration agreement with Genentech, a member of the Roche Group, to discover, develop and commercialize novel…
Read More...

Pandion Therapeutics, Inc., a biotechnology company developing modular protein therapeutics for autoimmune disease, announced the dosing of the first subject in a Phase 1 clinical trial…
Read More...